Ken Griffin’s CASI Pharmaceuticals CASI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42.8K Buy
+36,246
New +$42.8K ﹤0.01% 5503
2024
Q4
Sell
-22,714
Closed -$135K 6050
2024
Q3
$135K Buy
+22,714
New +$135K ﹤0.01% 4791
2024
Q1
Sell
-12,916
Closed -$93.9K 6163
2023
Q4
$93.9K Buy
+12,916
New +$93.9K ﹤0.01% 4897
2022
Q2
Sell
-15,271
Closed -$124K 6068
2022
Q1
$124K Buy
15,271
+13,483
+754% +$109K ﹤0.01% 5537
2021
Q4
$14K Sell
1,788
-1,154
-39% -$9.04K ﹤0.01% 6339
2021
Q3
$35K Buy
+2,942
New +$35K ﹤0.01% 6207
2020
Q3
Sell
-2,566
Closed -$64K 4711
2020
Q2
$64K Sell
2,566
-3,047
-54% -$76K ﹤0.01% 4318
2020
Q1
$115K Sell
5,613
-2,640
-32% -$54.1K ﹤0.01% 4309
2019
Q4
$255K Buy
+8,253
New +$255K ﹤0.01% 3995
2019
Q1
Sell
-2,253
Closed -$91K 4560
2018
Q4
$91K Buy
+2,253
New +$91K ﹤0.01% 4021
2018
Q2
Sell
-2,010
Closed -$84K 4192
2018
Q1
$84K Buy
2,010
+170
+9% +$7.1K ﹤0.01% 3660
2017
Q4
$60K Buy
+1,840
New +$60K ﹤0.01% 3592
2017
Q3
Sell
-2,071
Closed -$22K 3687
2017
Q2
$22K Buy
+2,071
New +$22K ﹤0.01% 3493
2016
Q4
Sell
-1,786
Closed -$20K 3609
2016
Q3
$20K Buy
+1,786
New +$20K ﹤0.01% 3416
2016
Q2
Sell
-1,709
Closed -$18K 3393
2016
Q1
$18K Sell
1,709
-262
-13% -$2.76K ﹤0.01% 3165
2015
Q4
$19K Buy
+1,971
New +$19K ﹤0.01% 3651
2015
Q2
Sell
-1,055
Closed -$16K 3814
2015
Q1
$16K Sell
1,055
-53
-5% -$804 ﹤0.01% 3614
2014
Q4
$15K Buy
+1,108
New +$15K ﹤0.01% 3708
2014
Q2
Sell
-1,279
Closed -$23K 3466
2014
Q1
$23K Buy
+1,279
New +$23K ﹤0.01% 3441